MURPHY ANDREW J sold REGN

March 14, 2024 · Form 4 insider transaction

MURPHY ANDREW J sold 196 shares of Regeneron Pharmaceuticals, Inc. at $968.20 per share, a transaction worth $189.8K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.

Direction
Disposed (sell-side)
Shares
196
Price
$968.20
Total value
$189.8K
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMarch 14, 2024
Filing dateMarch 15, 2024
Shares owned after48,306
OwnershipDirect
10b5-1 planYes
AmendedNo

Footnotes

Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on May 9, 2023.; Represents volume-weighted average price of sales of 196 shares of Company stock on March 14, 2024 at prices ranging from $968.15 to $968.38. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 14, 2024 at each separate price.

View the original Form 4 on SEC EDGAR
MURPHY ANDREW J sold REGN: March 14, 2024 | Insider Trading Screener